Comparison Chart Actinium Pharmaceuticals, Inc. Deutsche Boerse AG

Stocks

7AY1

US00507W2061

Biotechnology & Medical Research

Market Closed - Deutsche Boerse AG Other stock markets 02:03:21 2026-08-03 EDT			5-day change	1st Jan Change
0.7080 ^EUR	-0.56%		-4.45%	-39.80%

06-03	Actinium Pharmaceuticals Presents New Data on Atnm-400 Demonstrating Potent Activity in Prostate Cancer Models Resistant to All Three Approved Androgen Receptor Inhibitors	CI
06-01	Actinium Pharmaceuticals, Inc. Appoints Steffen Heeger as Chief Medical Officer	CI

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Compared values

		Sector	Change	5-day change	YTD change	1-year change	5-year change	Capi.	ST	MT	LT
	ACTINIUM PHARMACEUTICALS, INC.	Bio Therapeutic Drugs	-0.56%	-4.45%	-39.80%	-49.10%	-87.69%	26.26M	-	-	-